Skip to main content

Ranmore Fund Management Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2055400 COBHAM, X0

Position in REGN

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$18,706,200
New position
Shares Held
30,000
first reported quarter
Ownership
0.029%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#221
of 1,322 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ranmore Fund Management Ltd holds $18,706,200 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
30,000 $18,706,200

All Filings in REGN

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $18,706,200 30,000